Fit-for-Purpose COA Development: 25 years developing, modifying and validating PROs in more than 60 therapeutic categories. LEARN MORE

Translation Services: 25 years developing linguistically validated translations of COAs, CRFs, protocols, manuals, etc… READ MORE

QualityMetric By The Numbers: 53,000,000+ Global Survey administrations, 48,000+ Peer-reviewed articles across 100+ conditions, 200+ Language translations by mode of administrations, 100+ Condition-Specific, Country-Specific, and Insurance Claims Benchmarks General Population Norms. Which survey should you use? SEE OUR SUITE OF PRO SURVEYS

ePRO & EDC Integration: Seamless integration for optimal efficiencies using Web Service Application Programming Interface (API), Single Sign-on Access (SSO) or Electronic-Friendly Survey Administration. FIND OUT HOW
HIT-6 NEW PROS IN ONCOLOGY GUIDE

QM PROs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using PRO measures in a free oncology-focused guide.

Read the Guide

News

12.15.20

How We Identify the Best PRO Tools for Medical Device Manufacturers

Our experts provide medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.

 

On medical device manufacturers

 

The FDA encourages the integration of patient-reported outcome (PRO) instruments in the development, evaluation, and surveillance of medical device studies. For medical device manufacturers, determining the best PRO for your study can be challenging, but QualityMetric’s scientific team can help.

 

Our team can use its decades of experience in the development, modification, validation, implementation, and analysis of PROs in more than 60 therapeutic categories to help you select or adapt a PRO. These experts provide our medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.

Back to News